Prevention of Iron Deficiency in Infants and Toddlers



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

The prevalence of nutritional iron deficiency anemia in infants and toddlers has declined dramatically since 1960. However, satisfaction with this achievement must be tempered because iron deficiency anemia in infants and toddlers is associated with long-lasting diminished mental, motor, and behavioral functioning. Additionally, the prevalence of iron deficiency anemia in one- to three-year-old children seems to be increasing. The exact relationship between iron deficiency anemia and the developmental effects is not well understood, but these effects do not occur until iron deficiency becomes severe and chronic enough to produce anemia. At that point, treatment with iron can reverse the anemia and restore iron sufficiency, yet the poorer developmental functioning appears to persist. Therefore, intervention should focus on the primary prevention of iron deficiency. In the first year of life, measures to prevent iron deficiency include completely avoiding cow's milk, starting iron supplementation at four to six months of age in breastfed infants, and using iron-fortified formula when not breastfeeding. Low-iron formula should not be used. In the second year of life, iron deficiency can be prevented by use of a diversified diet that is rich in sources of iron and vitamin C, limiting cow's milk consumption to less than 24 oz per day, and providing a daily iron-fortified vitamin. All infants and toddlers who did not receive primary prevention should be screened for iron deficiency. Screening is performed at nine to 12 months, six months later, and at 24 months of age. The hemoglobin/hematocrit level alone detects only patients with enough iron deficiency to be anemic. Screening by erythrocyte protoporphyrin or red-cell distribution width identifies earlier stages of iron deficiency. A positive screening test is an indication for a therapeutic trial of iron, which remains the definitive method of establishing a diagnosis of iron deficiency.

A high prevalence of iron deficiency anemia in U.S. infants was first widely noted in the 1930s. Thirty years later, when the prevalence rate had not dropped,1 iron deficiency began to be seen as a significant public health problem. Because nutritional factors were the cause in the vast majority of these cases, iron deficiency anemia began to be referred to as nutritional anemia.1 It soon became standard to screen all infants between nine and 12 months of age for iron deficiency by screening for anemia. Anemia became the commonly employed marker for iron deficiency, and the hematocrit level became the screening test.

This universal screening strategy, in conjunction with an increase in the popularity of breastfeeding, iron-fortification of infant formulas and cereals, the start of the Special Supplemental Food Program for Women, Infants, and Children (WIC) in 1972, and education of physicians and the public, was extremely successful. By the mid-1980s, a dramatic decline in the prevalence of iron deficiency anemia was noticed across the socioeconomic spectrum throughout the United States.2 In 1971, 23 percent of nine- to 36-month-old children in an inner city clinic in New Haven, Conn., had a hemoglobin level below 9.8 g per dL (98 g per L).1 By 1984, the rate in the same clinic had dropped to 1 percent.3 A study of middle-class nine- to 23-month-old infants in a private practice in Minneapolis found that a 7.6 percent prevalence of anemia between 1969 and 1973 decreased to a prevalence of 2.8 percent between 1982 and 1986.4

This achievement in the reduction of iron deficiency anemia in children has been considered a major success story. By 1987, leaders in the field suggested that routine screening for iron deficiency was no longer indicated except in known high-risk populations and should be replaced by selective screening based on the individual patient's risk for iron deficiency.5 It appeared that although the medical community needed to remain vigilant and identify pockets of continued elevated prevalence, iron deficiency anemia was no longer the public health threat that it had been. Unfortunately, iron deficiency anemia is still with us, and its developmental effects appear to be long-lasting.

Mental, Motor, and Behavior Effects

The association between iron deficiency anemia and diminished mental, motor, and behavioral development in infants is not a recent discovery. A possible link was noted in the late 1970s,6 and subsequent studies of 12- to 23-month-old infants in the past two decades confirmed those findings.710 By the 1990s, the association between iron deficiency anemia and lower developmental test scores was well-established but may not have received the expected amount of attention in the United States because of the shrinking prevalence of iron deficiency anemia. In recent years, it has become clear that these effects are long-lasting despite correction of the iron deficiency anemia.

Mental, motor, and behavior effects develop only when iron deficiency is severe enough to cause anemia.7,8 In studies using Bayley Scales of Infant Development,7 infants with iron deficiency anemia receive lower scores on mental and motor tests, including gross and fine motor coordination,11 and demonstrate affective differences, such as wariness, fearfulness, and unhappiness.9 These findings have been confirmed by a variety of studies in different cultural settings.12 Further study of the behavior component found activity differences, with the anemic infants being less playful, tiring more easily, and preferring to be held.10 These mental and motor effects are not detectable on routine physical examination; it is not known if the behavior changes are noticeable.

Treatment with iron, with subsequent complete resolution of the anemia and the iron deficiency, does not correct all of the behavior effects.10 Furthermore, the lower mental and motor test scores associated with iron deficiency anemia persist.79 In the longest trial to date, children reevaluated at 11 to 14 years of age demonstrated functional impairment in school despite complete correction of the iron deficiency anemia they had as infants.13

These children were more likely to have repeated a grade, to have reduced arithmetic achievement and written expression, and to show differences in motor function, spatial memory and selective recall. In addition, their behavior was more likely to be characterized as problematic by parents and teachers.

Iron Deficiency Anemia After the First Year of Life

Historically, the prevention of iron deficiency anemia has focused on the first 12 months of life. It appears that toddlers deserve the same degree of attention because of the risk of developmental effects from iron deficiency anemia and because the prevalence of iron deficiency anemia between one and three years of age may be greater than was formerly thought.

Two large-scale studies, the Third National Health and Nutrition Examination Survey (NHANES III)14 and the Third Report on Nutrition Monitoring in the United States (1988–1991),15 reported the prevalence of iron deficiency anemia in one- to two-year-olds to be 3 percent, and in one- to three-year-olds to be 15 percent.

A more recent study, conducted in an urban setting with an equal mix of lower and middle socioeconomic groups, noted that 10 percent of one- to three-year-olds had iron deficiency anemia.15 Severe cases of iron deficiency anemia (hemoglobin level less than 6 g per dL [60 g per L]) have been reported in this age range as well.16 In a longitudinal study of toddlers, 12-month-olds were noted to be receiving nearly 100 percent of the recommended daily allowance (RDA) for iron, but by 18 months of age, the intake of iron had declined to a level well below the recommended amount.17

These findings might have been anticipated because one- to three-year-olds have the lowest daily iron intake of any age group across the lifespan.15 At one year, breastfeeding or iron-fortified formula is often replaced with cow's milk, non–iron-fortified cereals enter the diet, and juices reduce the child's appetite for solid food.

Primary Prevention

The primary prevention of iron deficiency anemia in infants and toddlers hinges on healthy feeding practices. In infants, the introduction of cow's milk in the first year of life is the greatest dietary risk factor for the development of iron deficiency and iron deficiency anemia.1820 Cow's milk is low in iron, and its iron is poorly absorbed.21 In addition, it decreases the absorption of iron from other dietary sources.21 Therefore, the strict avoidance of cow's milk in the first 12 months of life is essential in preventing iron deficiency anemia.

Breastfeeding is the ideal feeding practice for many well-documented reasons, including lowering the risk of iron deficiency anemia. Although breast milk is low in iron content, about 50 percent of the iron is bioavailable to the infant.12 Yet, exclusive breastfeeding after four to six months puts infants at risk for iron deficiency. Therefore, some form of dietary iron supplement that provides 1 mg elemental iron per kg per day is recommended for term infants starting at four22,23 to six12,20 months of age. Iron-fortified cereal can help meet this requirement24; however, many cereal-fed infants still develop iron deficiency anemia.25

To prevent iron deficiency, another option is a daily oral iron supplement, using ferrous sulfate drops26 or infant vitamin drops with iron. Vitamin drops contain 10 mg of elemental iron per dropper, which is the RDA for children six months to six years of age.26,27 Iron supplementation via drops or iron-fortified cereal should be continued throughout the period of breastfeeding. Breastfed preterm and low-birth-weight infants require supplementation at a dosage of 2 mg of oral elemental iron per kg per day, starting at two to four weeks of age.26 Infants weighing less than 1,500 g (3 lb, 4 oz) need higher dosages (3 mg per kg per day for 1,000 g [2 lb, 3 oz] to 1,500 g and 4 mg per kg per day for less than 1,000 g).12 All supplemental iron preparations, especially those for adults, should be stored out of the reach of children to prevent fatal poisonings.

Infants started on formula at birth and those switched from breast milk to formula should receive iron-fortified formula.28 Term and preterm infants (weighing more than 1,000 g) who are fed iron-fortified formulas are able to maintain iron sufficiency without additional iron supplementation.26,29 Vitamins given to these infants should not contain iron.

Low-iron formulas (less than 6.7 mg per L of iron) place infants at risk for iron deficiency anemia while offering no advantage over standard iron-fortified formulas with respect to gastrointestinal side effects.30 Controlled31 and double-blinded crossover32 trials show no difference between low- and standard-iron formulas in the frequency of fussiness, cramping, colic, regurgitation, flatus, or stool characteristics (except a darker color with standard iron-fortified formulas). Moreover, iron given at higher dosages to treat known iron deficiency anemia in 12-month-old infants caused no more gastrointestinal side effects than placebo.33

In the second year of life, cow's milk continues to cause problems in maintaining iron stores, and its consumption should be limited to less than 24 oz per day,34 with some clinicians calling for a stricter limit of 16 oz per day. Mothers who wish to continue to breast-feed after 12 months of age should be encouraged to do so, and iron supplementation should be maintained in some form. If breast-feeding is stopped before 24 months, a recent suggestion has been to substitute iron-fortified formula for cow's milk because of the negative effects of cow's milk on iron status.22 This may not be practical for many parents.

Other preventive measures for toddlers include encouraging a diversified diet rich in sources of iron and vitamin C, continuing use of cereals fortified with iron instead of more advertised cereals, avoiding excessive juice intake, and giving an iron-containing vitamin.15

Secondary Prevention

SCREENING

Infants with one or more risk factors (Table 1) should be screened for iron deficiency. Of these risks, the introduction of cow's milk in the first year of life is the most potent dietary factor for the development of iron deficiency.20 Poverty also significantly increases the risk for iron deficiency anemia, leading to the recommendation for continued routine screening of all infants from lower socioeconomic backgrounds.24 Forgoing screening might be considered if it is certain an infant has received primary prevention.

TABLE 1

Risk Factors for Iron Deficiency in the First Year of Life

Diet

Cow's milk ingestion

Low-iron formula

Breastfeeding without iron supplementation

Prenatal/perinatal

Anemia during pregnancy

Poorly controlled diabetes

Low birth weight

Prematurity

Multiple gestation

Socioeconomic

Low socioeconomic background

Recent immigration from a developing country

Other

Qualified for but not receiving WIC assistance

Rate of weight gain greater than average


WIC = Special Supplemental Food Program for Women, Infants, and Children.

TABLE 1   Risk Factors for Iron Deficiency in the First Year of Life

View Table

TABLE 1

Risk Factors for Iron Deficiency in the First Year of Life

Diet

Cow's milk ingestion

Low-iron formula

Breastfeeding without iron supplementation

Prenatal/perinatal

Anemia during pregnancy

Poorly controlled diabetes

Low birth weight

Prematurity

Multiple gestation

Socioeconomic

Low socioeconomic background

Recent immigration from a developing country

Other

Qualified for but not receiving WIC assistance

Rate of weight gain greater than average


WIC = Special Supplemental Food Program for Women, Infants, and Children.

Screening in the first year is performed between nine26 and 12 months of age.24 Special consideration is given to preterm and low-birth-weight infants, who are screened at six months of age and by three months for those who have not received oral iron supplements or iron-fortified formula.26

After 12 months, any toddler who was at risk as an infant but not screened needs to be tested at that time for iron deficiency. Other toddlers at risk (e.g., past history of iron deficiency anemia, cow's milk consumption of more than 24 oz per day, diet low in iron and vitamin C, or recent immigration from a developing country) should be screened between 15 and 18 months and at 24 months.34 A positive screening test requires confirmation with a therapeutic trial of iron. A negative screen provides an opportunity to intervene with primary prevention.

The ideal screening test would be capable of identifying iron deficiency in the absence of anemia. This would allow for the treatment of iron deficiency in the pre-anemic stage, preventing iron deficiency anemia and its associated mental, motor, and behavior effects. No such test is widely used at this time. The standard test has been the hemoglobin (or hematocrit) level, which leads to the diagnosis only if the iron deficiency is severe enough to cause anemia. This approach has been called into question because the developmental consequences of iron deficiency anemia suggest that identification of iron deficiency before anemia would be preferable.35

The serum ferritin level, transferrin saturation, and erythrocyte protoporphyrin level also can be used in the diagnosis of iron deficiency (Figure 1).36 Of these, the erythrocyte protoporphyrin measurement has the advantages of lower cost and office-based availability. Clinical studies have demonstrated its effectiveness as a screening tool.37,38 While an elevated erythrocyte protoporphyrin level is not as specific for iron deficiency as other markers, the decline in the prevalence and severity of lead toxicity makes an elevated erythrocyte protoporphyrin level a likely positive screen for iron deficiency.

Stages of Iron Deficiency

FIGURE 1.

Stages of iron deficiency. (Hgb = hemoglobin; EP = erythrocyte protoporphyrin; RDW = red-cell distribution width; MCV = mean corpuscular volume)

Note: Cut-off values are for infants.

Adapted with permission from Dallman PR. Iron deficiency: diagnosis and treatment. West J Med 1981; 134:498.

View Large

Stages of Iron Deficiency


FIGURE 1.

Stages of iron deficiency. (Hgb = hemoglobin; EP = erythrocyte protoporphyrin; RDW = red-cell distribution width; MCV = mean corpuscular volume)

Note: Cut-off values are for infants.

Adapted with permission from Dallman PR. Iron deficiency: diagnosis and treatment. West J Med 1981; 134:498.

Stages of Iron Deficiency


FIGURE 1.

Stages of iron deficiency. (Hgb = hemoglobin; EP = erythrocyte protoporphyrin; RDW = red-cell distribution width; MCV = mean corpuscular volume)

Note: Cut-off values are for infants.

Adapted with permission from Dallman PR. Iron deficiency: diagnosis and treatment. West J Med 1981; 134:498.

Practices with a large number of infant and toddler patients at risk for iron deficiency or a high prevalence of iron deficiency anemia may find it helpful to invest in an office hematofluorimeter to measure erythrocyte protoporphyrin. As a screening test, it will miss some cases of iron deficiency even in the presence of anemia, making the combination of erythrocyte protoporphyrin and hemoglobin measurement a more effective screening strategy.

If erythrocyte protoporphyrin measurement is not an option, obtaining a red-cell distribution width (RDW) with the hemoglobin measurement could be a consideration.14 An elevated RDW is believed to be an early indicator of iron deficiency and might prompt a therapeutic trial of iron (Figure 2) to confirm the diagnosis.12 This is an attractive approach because the complete blood count (CBC) with red blood cell indexes alone could be used to screen for iron deficiency and iron deficiency anemia. However, this use of RDW is not currently standard practice, and cut-off values for RDW are instrument-specific and must be known by the ordering clinician.

Therapeutic Trial of Iron to Diagnose Iron Deficiency

FIGURE 2.

Therapeutic trial of iron to diagnose iron deficiency. (Hgb = hemoglobin)

*--Twenty percent of ferrous sulfate is elemental iron.

NOTE: If hematocrit is used as screening test, a three-unit increase is diagnostic.

View Large

Therapeutic Trial of Iron to Diagnose Iron Deficiency


FIGURE 2.

Therapeutic trial of iron to diagnose iron deficiency. (Hgb = hemoglobin)

*--Twenty percent of ferrous sulfate is elemental iron.

NOTE: If hematocrit is used as screening test, a three-unit increase is diagnostic.

Therapeutic Trial of Iron to Diagnose Iron Deficiency


FIGURE 2.

Therapeutic trial of iron to diagnose iron deficiency. (Hgb = hemoglobin)

*--Twenty percent of ferrous sulfate is elemental iron.

NOTE: If hematocrit is used as screening test, a three-unit increase is diagnostic.

If obtaining a CBC or an erythrocyte protoporphyrin level is impractical, screening solely with hemoglobin should not be abandoned. It is better to discover a patient who has developed iron deficiency anemia than to miss the diagnosis, as severity and chronicity of the condition may worsen the outcome. Another reason to keep hemoglobin as part of the screening strategy is that a baseline hemoglobin level is ultimately necessary in the confirmation of the diagnosis of iron deficiency.39 When the erythrocyte protoporphyrin level is elevated or the hemoglobin is low (less than 11 g per dL [110 g per L]), a therapeutic trial of oral iron is the gold standard to establish the diagnosis of iron deficiency.40 Black infants normally have slightly lower hemoglobin levels, and a cutoff of 10.7 g per dL [107 g per L] defines anemia in this population.26

A therapeutic trial of iron is the preferred approach to diagnosing iron deficiency because it is more reliable and less expensive than obtaining an iron panel.41,42 In children, it is important to remember that a recent infection can transiently depress the hemoglobin.43,44 Therefore, it is recommended to delay testing in an infant or toddler who had an infection within the previous two weeks.26 If the therapeutic trial of iron is negative, a work-up for the etiology of the anemia is indicated.

Other hematopoietic markers are being evaluated for their potential to simultaneously screen for and diagnose iron deficiency in infants and toddlers. The serum circulating transferrin receptor assay is a relatively new test, and the most recent test of iron status to be suggested is reticulocyte hemoglobin content.45 Neither modality is widely available, and both need more clinical study.

TREATMENT

After a positive screening test for iron deficiency and a diagnosis confirmed by a therapeutic trial of iron, the infant or toddler should complete a course of iron therapy. Elemental iron, at a dosage of 3 mg per kg, is given orally (usually as ferrous sulfate syrup, which is 20 percent elemental iron) once daily before breakfast.21,26 Absorption is improved if it is ingested with a source of vitamin C, such as orange juice. Total length of treatment is three months, including the one-month therapeutic trial of iron.26

The Author

LOUIS A. KAZAL, JR., M.D., is a Robert Wood Johnson health policy fellow at the Institute of Medicine in Washington D.C., and is chief medical officer of the Navajo Health Foundation/Sage Memorial Hospital in Ganado, Ariz. A graduate of Jefferson Medical College, Philadelphia, he completed a residency in family practice at McKay-Dee Hospital Center, Ogden, affiliate of the University of Utah School of Medicine. Dr. Kazal holds a volunteer faculty appointment as clinical associate professor in the Department of Family and Community Medicine at Baylor College of Medicine, Houston.

Address correspondence to Louis A. Kazal, Jr., M.D., Dartmouth-Hitchcock Community Health Center, One Medical Center Dr., Lebanon, NH 03766. Reprints are not available from the author.

The author indicates that he does not have any conflicts of interest. Sources of funding: none reported.

The author thanks Carmen James and Eva Hubbard Grabarek for assistance with the manuscript and Anthony F. Valdini, M.D., for editorial input.

REFERENCES

1. Katzman R, Novack A, Pearson H. Nutritional anemia in an inner-city community. Relationship to age and ethnic group. JAMA. 1972;222:670–3.

2. Yip R, Binkin NJ, Fleshood L, Trowbridge FL. Declining prevalence of anemia among low-income children in the United States. JAMA. 1987;258:1619–23.

3. Vazquez-Seoane P, Windom R, Pearson HA. Disappearance of iron-deficiency anemia in a high-risk infant population given supplemental iron. N Engl J Med. 1985;313:1239–40.

4. Yip R, Walsh KM, Goldfarb MG, Binkin NJ. Declining prevalence of anemia in childhood in a middle-class setting: a pediatric success story?. Pediatrics. 1987;80:330–4.

5. Dallman PR. Has routine screening of infants for anemia become obsolete in the United States?. Pediatrics. 1987;80:439–41.

6. Oski FA. The nonhematologic manifestations of iron deficiency. Am J Dis Child. 1979;133:315–22.

7. Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, et al. Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics. 1987;79:981–95.

8. Walter T, De Andraca I, Chadud P, Perales CG. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics. 1989;84:7–17.

9. Lozoff B, Wolf AW, Jimenez E. Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J Pediatr. 1996;129:382–9.

10. Lozoff B, Klein NK, Nelson EC, McClish DK, Manuel M, Chacon ME. Behavior of infants with iron-deficiency anemia. Child Dev. 1998;69:24–36.

11. Oski FA, Honig AS. The effects of therapy on the developmental scores of iron-deficient infants. J Pediatr. 1978;92:21–5.

12. Oski FA. Iron deficiency in infancy and child-hood. N Engl J Med. 1993;329:190–3.

13. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics. 2000;105:E51.

14. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973–6.

15. Eden AN, Mir MA. Iron deficiency in 1- to 3-year-old children. A pediatric failure?. Arch Pediatr Adolesc Med. 1997;151:986–8.

16. Kwiatkowski JL, West TB, Heidary N, Smith-Whitley K, Cohen AR. Severe iron deficiency anemia in young children. J Pediatr. 1999;135:514–6.

17. Picciano MF, Smiciklas-Wright H, Birch LL, Mitchell DC, Murray-Kolb L, McConahy KL. Nutritional guidance is needed during dietary transition in early childhood. Pediatrics. 2000;106(1 pt 1):109–14.

18. Sadowitz PD, Oski FA. Iron status and infant feeding practices in an urban ambulatory center. Pediatrics. 1983;72:33–6.

19. Tunnessen WW Jr, Oski FA. Consequences of starting whole cow milk at 6 months of age. J Pediatr. 1987;111(6 pt 1):813–6.

20. Pizarro F, Yip R, Dallman PR, Olivares M, Her-trampf E, Walter T. Iron status with different infant feeding regimens: relevance to screening and prevention of iron deficiency. J Pediatr. 1991;118:687–92.

21. Dallman PR, Siimes MA, Stekel A. Iron deficiency in infancy and childhood. Am J Clin Nutr. 1980;33:86–118.

22. Booth IW, Aukett MA. Iron deficiency anaemia in infancy and early childhood. Arch Dis Child. 1997;76:549–54.

23. Calvo EB, Galindo AC, Aspres NB. Iron status in exclusively breast-fed infants. Pediatrics. 1992;90:375–9.

24. Screening for iron deficiency anemia—including iron prophylaxis. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2d ed. Baltimore: Williams & Wilkins, 1996;231–46.

25. Walter T, Dallman PR, Pizarro F, Velozo L, Pena G, Bartholmey SJ, et al. Effectiveness of iron-fortified infant cereal in prevention of iron deficiency anemia. Pediatrics. 1993;91:976–82.

26. Earl RO, Woteki CE, Institute of Medicine Committee on the Prevention, Detection, and Management of Iron Deficiency Anemia Among U.S. Children and Women of Childbearing Age. Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among U.S. children and women of childbearing age. Washington, D.C.: National Academy Press, 1993.

27. Filer LJ Jr. Iron needs during rapid growth and mental development. J Pediatr. 1990;117(2 pt 2):S143–6.

28. American Academy of Pediatrics Committee on Nutrition. Iron-fortified infant formulas. Pediatrics. 1989;84:1114–5.

29. Irigoyen M, Davidson LL, Carriero D, Seaman C. Randomized, placebo-controlled trial of iron supplementation in infants with low hemoglobin levels fed iron-fortified formula. Pediatrics. 1991;88:320–6.

30. American Academy of Pediatrics Committee on Nutrition. Iron fortification of infant formulas. Pediatrics. 1999;104(1 pt 1):119–23.

31. Oski FA. Iron-fortified formulas and gastrointestinal symptoms in infants: a controlled study. Pediatrics. 1980;66:168–70.

32. Nelson SE, Ziegler EE, Copeland AM, Edwards BB, Fomon SJ. Lack of adverse reactions to iron-fortified formula. Pediatrics. 1988;81:360–4.

33. Reeves JD, Yip R. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants. Pediatrics. 1985;75:352–5.

34. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. Morb Mortal Wkly Rev MMWR. 1998;47(RR-3):1–29.

35. Kazal LA Jr. Failure of hematocrit to detect iron deficiency in infants. J Fam Pract. 1996;42:237–40.

36. Dallman PR. Iron deficiency: diagnosis and treatment. West J Med. 1981;134:496–505.

37. Yip R, Schwartz S, Deinard AS. Screening for iron deficiency with the erythrocyte protoporphyrin test. Pediatrics. 1983;72:214–9.

38. Siegel RM, LaGrone DH. The use of zinc protoporphyrin in screening young children for iron deficiency. Clin Pediatr [Phila]. 1994;33:473–9.

39. Dallman PR, Yip R. Changing characteristics of childhood anemia. J Pediatr. 1989;114:161–4.

40. Reeves JD, Vichinsky E, Addiego J Jr, Lubin BH. Iron deficiency in health and disease. Adv Pediatr. 1983;30:281–320.

41. Dallman PR. Biochemical and hematologic indices of iron deficiency. In: Pollitt E, Leibel RL, eds. Iron deficiency: brain biochemistry and behavior. New York: Raven, 1982:63–77.

42. Driggers DA, Reeves JD, Lo EY, Dallman PR. Iron deficiency in one-year-old infants: comparison of results of a therapeutic trial in infants with anemia or low-normal hemoglobin values. J Pediatr. 1981;98:753–8.

43. Reeves JD, Yip R, Kiley VA, Dallman PR. Iron deficiency in infants: the influence of mild antecedent infection. J Pediatr. 1984;105:874–9.

44. Olivares M, Walter T, Osorio M, Chadud P, Schlesinger L. Anemia of a mild viral infection: the measles vaccine as a model. Pediatrics. 1989;84:851–5.

45. Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225–30.



Copyright © 2002 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article